Zacks Research Has Pessimistic View of Allstate Q1 Earnings

The Allstate Co. (NYSE:ALLFree Report) – Equities researchers at Zacks Research dropped their Q1 2025 EPS estimates for Allstate in a note issued to investors on Wednesday, February 19th. Zacks Research analyst Z. Masood now forecasts that the insurance provider will post earnings per share of $4.14 for the quarter, down from their previous estimate of $5.12. The consensus estimate for Allstate’s current full-year earnings is $18.74 per share. Zacks Research also issued estimates for Allstate’s Q4 2025 earnings at $6.46 EPS, FY2025 earnings at $17.94 EPS, Q2 2026 earnings at $4.00 EPS, Q3 2026 earnings at $4.67 EPS, Q4 2026 earnings at $7.35 EPS and FY2026 earnings at $21.25 EPS.

A number of other research firms have also commented on ALL. Piper Sandler lifted their price objective on Allstate from $206.00 to $244.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 26th. Barclays dropped their target price on Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a report on Monday, January 6th. Wells Fargo & Company lifted their price target on shares of Allstate from $186.00 to $187.00 and gave the company an “equal weight” rating in a report on Tuesday, January 14th. Evercore ISI raised shares of Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. Finally, Jefferies Financial Group increased their target price on Allstate from $231.00 to $267.00 and gave the stock a “buy” rating in a report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $217.94.

Check Out Our Latest Stock Report on ALL

Allstate Trading Up 1.0 %

NYSE:ALL opened at $190.66 on Monday. The company has a quick ratio of 0.40, a current ratio of 0.36 and a debt-to-equity ratio of 0.42. The company’s 50 day moving average is $190.06 and its 200-day moving average is $190.70. The firm has a market cap of $50.49 billion, a price-to-earnings ratio of 11.22, a P/E/G ratio of 1.01 and a beta of 0.52. Allstate has a 12 month low of $153.87 and a 12 month high of $209.88.

Allstate (NYSE:ALLGet Free Report) last posted its earnings results on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%.

Insider Transactions at Allstate

In other news, CFO Jesse E. Merten sold 40,102 shares of the business’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the transaction, the chief financial officer now owns 18,115 shares of the company’s stock, valued at $3,378,990.95. The trade was a 68.88 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.80% of the company’s stock.

Hedge Funds Weigh In On Allstate

Several institutional investors and hedge funds have recently made changes to their positions in ALL. Chicago Partners Investment Group LLC boosted its stake in Allstate by 1.3% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock worth $893,000 after purchasing an additional 59 shares during the period. Carmichael Hill & Associates Inc. raised its holdings in shares of Allstate by 15.0% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock valued at $87,000 after purchasing an additional 60 shares during the period. Apella Capital LLC raised its stake in Allstate by 1.9% in the fourth quarter. Apella Capital LLC now owns 3,231 shares of the insurance provider’s stock valued at $623,000 after buying an additional 60 shares during the period. Intrust Bank NA raised its stake in Allstate by 0.5% in the fourth quarter. Intrust Bank NA now owns 12,135 shares of the insurance provider’s stock valued at $2,340,000 after buying an additional 61 shares during the period. Finally, Avior Wealth Management LLC raised its position in shares of Allstate by 4.9% in the third quarter. Avior Wealth Management LLC now owns 1,329 shares of the insurance provider’s stock valued at $252,000 after purchasing an additional 62 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

About Allstate

(Get Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

See Also

Earnings History and Estimates for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.